Management of Hepatitis C–Infected Patients After Sustained Virological Response
Brian Pearlman – 21 July 2020
Management of Hepatitis C–Infected Patients After Sustained Virological Response
Brian Pearlman – 21 July 2020
Issue Information
21 July 2020
HCV Elimination in a Health Network Serving Indigenous Communities in Northern California
Kathleen Cassel, Gregory Carlson – 21 July 2020
The Current Status of US and Global Access to Direct‐Acting Antiviral Regimens for Hepatitis C Virus Infection
Camilla S. Graham – 21 July 2020
Novel Models of Hepatitis C Virus Care Delivery: Telemedicine, Project ECHO, and Integrative Care
Sanjeev Arora, Karla Thornton – 21 July 2020
Issue Information
21 July 2020
Liver Chemistries in Patients With COVID‐19 Who Were Discharged Alive or Died: A Meta‐analysis
Qing‐Qing Xing, Xuan Dong, Yan‐Dan Ren, Wei‐Ming Chen, Dan‐Yi Zeng, Yan‐Yan Cai, Mei‐Zhu Hong, Jin‐Shui Pan – 21 July 2020 – Although abnormal liver chemistries are linked to a higher risk of coronavirus disease 2019 (COVID‐19)–related death, liver manifestations may be diverse and even confusing. Thus, we performed a meta‐analysis of published liver manifestations and described the liver damage in patients with COVID‐19 who died or discharged alive.
Liver Chemistries in Patients With COVID‐19 Who Were Discharged Alive or Died: A Meta‐analysis
Qing‐Qing Xing, Xuan Dong, Yan‐Dan Ren, Wei‐Ming Chen, Dan‐Yi Zeng, Yan‐Yan Cai, Mei‐Zhu Hong, Jin‐Shui Pan – 21 July 2020 – Although abnormal liver chemistries are linked to a higher risk of coronavirus disease 2019 (COVID‐19)–related death, liver manifestations may be diverse and even confusing. Thus, we performed a meta‐analysis of published liver manifestations and described the liver damage in patients with COVID‐19 who died or discharged alive.